Novartis Pharmaceuticals Corporation develops and markets several types of patent-protected prescription drugs. The company provides a selection of injections and tablets for cystic fibrosis, diabetes, eczema and epilepsy. It has research capabilities in the areas of neuroscience, musculoskeletal diseases, and autoimmunity and transplantation. Novartis Pharmaceuticals Corporation manufactures and markets prescription drugs to treat various heath conditions related to cardiovascular, respiratory, metabolic and central nervous systems. The company additionally provides medications for the treatment of patients suffering from various dermatological and gastrointestinal diseases. It offers product under the trade names of Voltaren, Ritalin, Lamisil, Gleevec and Enablex. Novartis Pharmaceuticals Corporation has operations in more than 140 countries.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.